1. Benua RS, Cicale NR, Sonenberg M, Rawson RW. The relation of 131I dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol Radium Ther Nucl Med. 1962;87:171–82.
2. Alexander C, Bader JB, Schaefer A, et al. Intermediate and long-term side effects of high-dose 131I therapy for thyroid carcinoma. J Nucl Med. 1998;39:1551–4.
3. Chiu AC, Delpass ES, Sherman SI. Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab. 1997;82:3637–42.
4. Holmquest DL, Lake P. Sudden hemorrhage in metastatic thyroid carcinoma of the brain during treatment with iodine-I31. J Nucl Med. 1976;17:307–9.
5. Datz FL. Cerebral edema following iodine-131 therapy for thyroid carcinoma metastatic to the brain. J Nucl Med. 1986;27:637–40.